Cargando…
In situ genetic engineering of tumors for long-lasting and systemic immunotherapy
Cancer immunotherapy has been the subject of extensive research, but highly effective and broadly applicable methods remain elusive. Moreover, a general approach to engender endogenous patient-specific cellular therapy, without the need for a priori knowledge of tumor antigen, ex vivo cellular manip...
Autores principales: | Tzeng, Stephany Y., Patel, Kisha K., Wilson, David R., Meyer, Randall A., Rhodes, Kelly R., Green, Jordan J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049107/ https://www.ncbi.nlm.nih.gov/pubmed/32034097 http://dx.doi.org/10.1073/pnas.1916039117 |
Ejemplares similares
-
Biodegradable lipophilic polymeric mRNA nanoparticles for ligand-free targeting of splenic dendritic cells for cancer vaccination
por: Ben-Akiva, Elana, et al.
Publicado: (2023) -
Biomaterial-Mediated Genetic Reprogramming of Merkel
Cell Carcinoma and Melanoma Leads to Targeted Cancer Cell Killing In Vitro and In Vivo
por: Luly, Kathryn M, et al.
Publicado: (2023) -
The renaissance of life near the boiling point – at last, genetics and metabolic engineering
por: Adams, Michael W.W., et al.
Publicado: (2016) -
Life on the edge—a changing genetic landscape within an iconic American pika metapopulation over the last half century
por: Klingler, Kelly B., et al.
Publicado: (2023) -
An engineered immunocytokine with collagen affinity improves the tumor bioavailability, tolerability, and therapeutic efficacy of IL-2
por: Silver, Aliyah B., et al.
Publicado: (2023)